Total Funding
61
33
Total FundingPost-IPO Equity raised
Growth Score 61 in past quarter
16 pts
Heat Score 33 in past quarter
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
45346
Atrys is a biomedical company dedicated to provide diagnostic services and excelence medical treatments.
- Cordon Cardo Carlos: Scientific vice chair
- Zvi Fuchs: Founder and Medical Vice President
About the Company
ATRYS is an innovative biomedical company dedicated to the provision of specialized diagnostic services and advanced medical treatments. ATRYS combines precision diagnostic techniques in pathological and molecular anatomy, and online diagnostic imaging, with new treatments for radiation oncology. It has offices in Barcelona, Granada and Madrid.